Proven expertise in delivering high-quality clinical trial imaging data at a global scale to worldwide biopharmaceutical organizations and CROs for nearly 30 years.
With nearly 30 years of experience, Perceptive is the choice you can trust for:
Backed by industry-leading scientific/medical leaders and an executive team who bring deep clinical trial experience to every study, Perceptive backs your clinical trial with the largest and most diverse team of therapeutically-aligned experts, including radiologists, PhDs, and technologists, who know how to get your imaging done right.
Rely on our local study delivery teams in China, India, Europe, and North America to anticipate your needs and scale our services to deliver quick and reliable continuity of service, ensuring efficient site setup to meet trial timelines and providing dedicated teams for quality control support.
We know you put your trust in us to deliver imaging data that is accurate, reliable, and holds up against regulatory scrutiny, so we are committed to first-time quality. We ensure quality drives everything we do, as evidenced by our successful inspection track record and support of 370+ approvals across various regulatory authorities, including the FDA, EMA and NMPA.
25%
Of all imaging trials supported since 1997
100+
Countries with trial operations
50,000
Monthly imaging capacity
370+
Regulatory approvals
Perceptive’s extensive experience in clinical trial imaging spans a wide range of therapeutic areas, varying degrees of complexity, and in all phases of clinical development.
Perceptive has the industry’s most extensive experience in solid tumor clinical trial imaging, with leading, internal scientific and medical experts who are dedicated to imaging core lab services. They apply therapeutic, modality, and response criteria expertise as they deliver advanced and standard-of-care imaging to your clinical trial.
We’ve supported over 150 solid tumor regulatory approvals involving the entire span of imaging modalities utilized in patient care.
Perceptive’s imaging core lab services have been proven to meet the unique challenges of multiple myeloma, lymphoma, leukemia, and myelofibrosis clinical trials head on. You can rely on our proven and scalable integrated imaging and clinical data workflows and our specialized, multi-modality expertise to meet the most complex trial needs.
Learn how we repeatedly deliver on tight timelines without compromising data quality, so you can have confidence that your imaging data is high-quality and regulator ready.
Having supported over 80% of radioligand therapy (RLT) and theranostics companies, Perceptive is the leading imaging service provider for radiopharmaceutical development. We support the full lifecycle of RLT and theranostics trials — ensuring patient safety from early-phase dose optimization through global Phase III.
With the right infrastructure, scientific expertise, and advanced imaging technology, we deliver high-quality imaging data that accelerates development and drives regulatory success to bring life-saving treatments to patients.
Having played a pivotal role in developing and validating nearly every amyloid and tau imaging tracer, and with a proven track record in advanced neuroimaging, Perceptive is the world’s leading CNS imaging solution provider for first-in-human through Phase IV global studies.
Whether you’re developing a disease-modifying therapy for Alzheimer’s, a novel tracer for Parkinson’s, or exploring novel endpoints in rare neuropsychiatric disorders, Perceptive’s medical imaging core lab is your partner for precision, speed, and regulatory-ready data.
Perceptive’s imaging core lab services have been proven to meet the challenges of multiple myeloma, lymphoma, leukemia, and myelofibrosis clinical trials head on. We work with a broad network of KOLs, featuring renowned advisors and internal experts, and consistently deliver on tight timelines without compromising data quality—so you can trust your imaging data is high-quality and regulatory-ready.
Having supported over 360 malignant hematology trials and 69 regulatory approvals, Perceptive’s imaging core lab services are proven ready.
Blood disorder trials involve multiple imaging modalities to support efficacy / safety endpoints and lack standardized response criteria. So, it’s critical that sponsors work with an imaging core lab who has specialized expertise to tackle these challenges.
For example, in Sickle Cell Disease trials, neuroimaging, transcranial Doppler, and CT are required, and Beta Thalassemia trials rely on cardiac MRI to assess iron overload and cardiac function – areas in which Perceptive Imaging has extensive experience you can rely on.
Having supported over 80% of radioligand therapy (RLT) and theranostics companies, Perceptive is the leading service provider for radiopharmaceutical development. We support the full lifecycle, ensuring patient safety from early-phase dose optimization and biodistribution through global Phase III execution.
With the right infrastructure, scientific expertise, and advanced imaging technology, we deliver high-quality data that accelerates development timelines and drives regulatory success to help you bring life-saving treatments to patients in need.
The development of GLP-1 agonists and other therapies for weight loss and obesity is evolving, and so is the advancement of imaging biomarkers for body composition profiling. Learn why you can rely on scientific experts at Perceptive Imaging to identify appropriate techniques to meet your weight loss clinical trial objectives.
Our in-depth understanding of the different modalities involved in body composition imaging, including DXA, CT, and MRI, can help you reliably measure muscle and fat changes in the whole body or at specific anatomic locations.
Perceptive is uniquely positioned to deliver reliable imaging data to support your rheumatology clinical development programs. We have significant experience using X-ray and MRI-based assessments to support eligibility, stratification, and/or efficacy endpoints in Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, and Osteoarthritis clinical trials.
Our scientific leadership and operations teams work diligently with you to provide technical and imaging expertise and effective site training for consistent image acquisition you can rely on.
Perceptive has extensive experience with body composition imaging related to muscle and fat changes in whole body or specific anatomic locations, and in disorders such as Diabetes, Sarcopenia, Duchene Muscular Dystrophy, metabolic dysfunction, and Obesity/weight loss.
Gain access to Perceptive’s scientists, delivering therapeutic and technical expertise in imaging modalities − including DXA, CT, MRI − protocol design, and standardizing image acquisition across global investigative sites to drive your clinical development program’s success.
Perceptive Imaging has supported 70 Osteoporosis/bone mineral density trials with various drug candidates and biosimilars. Our staff has extensive experience with Osteoporosis research/imaging, including DXA and X-ray-related endpoints.
Additionally, we have expertise in the field of bone age assessments in growth hormone deficiencies, including Bone Mineral Density assessments and T and Z score assessment by DXA, in both adult and pediatric studies.
Perceptive provides expert imaging support for cardiovascular trials, leveraging advanced modalities like echocardiography, cardiac MRI, CT angiography, MUGA, and scintigraphy to assess eligibility, efficacy, safety endpoints. Our AI-powered software reviews imaging data.
We’ve supported trials in diseases, rare indications including HOCM, ATTR-CM, Fabry disease, and Friedreich Ataxia. From site qualification through data delivery, our end-to-end process ensures reliable execution, driving trial success.
Perceptive supports GI clinical trials across diverse indications and imaging modalities, including MRI for Crohn’s disease and MASH, ultrasound for liver and biliary assessments, and video imaging for eosinophilic and ulcerative conditions. Our scientific and operational teams collaborate with key opinion leaders and expert readers to meet your trial’s unique imaging needs.
With in-house expertise and experience across 50+ trials, we deliver end-to-end imaging services from site qualification to final data delivery.
Perceptive is at forefront of recent advancements in pulmonary imaging assessments. Through partnerships with leaders in AI-driven texture analysis, we deliver objective, reproducible imaging assessments for indications like IPF and Chronic Sinusitis, guiding high-quality HRCT acquisition to ensure quantitative data analysis is highest quality. Experienced reviewers provide qualitative reads for Asthma, COPD, RSV, and Sarcoidosis.
From acquisition to analysis, Perceptive supports every step to ensure reliable data for success.
Perceptive has supported over 55 trials with ophthalmology-based safety and efficacy endpoints, across all phases and therapeutic areas. Our team delivers imaging and functional testing solutions from anterior segment to visual cortex using modalities like photo protocols, ultrasound, MRI, and novel approaches.
We combine deep expertise overcoming ocular imaging challenges, collaborations with reading centers, academic labs, independent ophthalmologists to tailor imaging workflows that meet your trial’s specific needs.
Perceptive Imaging specializes in volumetric analysis using CT, MRI, and ultrasound. We’ve supported clinical trials across indications where imaging assessed spleen, liver, kidney, lung, uterus, muscle, brain, and heart volume. We also measure sub-anatomical structures and abnormal tissue, such as fibrotic lung in IPF and plaque in ASCVD, leveraging tools from digital calipers to AI-assisted software, tailored to clinical trial endpoints. Perceptive has supported regulatory approval studies including Myelofibrosis and ADPKD.
Perceptive’s best in class reader program gives you access to a global network of over 1,300 subspecialty radiologists, neuroradiologists, and therapeutic experts for your trial’s important image reviews.
Our dedicated scientific operations team works with leading global institutions to draft your imaging charter, then selects and trains the most experienced reviewers based on your trial’s specific imaging needs. We leverage various reviewer performance monitoring methods and adhere to rigorous quality control processes to ensure the highest standards of image and clinical data analysis throughout your trial.
Perceptive is at the forefront in the evolution of medical imaging analysis. One example is the groundbreaking VISION trial, in which Perceptive’s semi-automated PSMA segmentation methodology opened the door for using AI to improve trial imaging.
Perceptive is still the only imaging core lab to support an FDA submission using AI-derived quantitative PET data and we continue to advance the methodology.
And we consistently look for opportunities to advance clinical trial imaging to better inform safety and efficacy determinations through image science and engineering and AI/ML.
Perceptive offers proactive, collaborative study management to ensure seamless, timely execution of clinical imaging core lab workflows. Our global expertise spans the entire imaging process, ensuring high-quality, regulatory-compliant results that drive successful clinical trial imaging.
With a resolute team of professional project managers being supported by the wealth of knowledge and experience within our scientific leadership team, we provide comprehensive imaging support and deliver high-quality data to streamline your decision-making.
